Transcat, Inc. (TRNS) Cash Flow Statement
Transcat, Inc. (TRNS) generated $40.0M of operating cash flow over the twelve months to 2026-06-30, spent $14.7M on capital expenditure and had free cash flow of $25.4M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TRNSTranscat, Inc.Follow TRNS — free
—
Price chart with a free account
- Market cap
- 766.8M
- P/E TTM
- 227.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2012 Mar 12 | FY2013 Mar 13 | FY2014 Mar 14 | FY2015 Mar 15 | FY2016 Mar 16 | FY2017 Mar 17 | FY2018 Mar 18 | FY2019 Mar 19 | FY2020 Mar 20 | FY2021 Mar 21 | FY2022 Mar 22 | FY2023 Mar 23 | FY2024 Mar 24 | FY2025 Mar 25 | FY2026 Mar 26 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 6.3 | 5.2 | 7.6 | 4.4 | 11.0 | 7.5 | 9.9 | 12.6 | 11.6 | 23.6 | 17.6 | 17.0 | 32.6 | 39.0 | 34.9 | 40.0 | |
| Capital expenditure | 1.4 | 2.7 | 2.0 | 3.5 | 4.1 | 5.3 | 5.9 | 7.0 | 6.6 | 6.6 | 10.2 | 9.4 | 13.3 | 13.2 | 15.3 | -14.7 | |
| Free cash flow | 4.9 | 2.6 | 5.7 | 0.9 | 6.9 | 2.3 | 4.0 | 5.6 | 5.0 | 17.0 | 7.5 | 7.5 | 19.3 | 25.8 | 19.6 | 25.4 | |
| Share repurchases | 0.2 | 0.1 | 6.5 | 0.1 | 0.1 | 0.1 | 0.4 | 0.1 | 2.8 | 3.0 | 6.7 | 0.4 | 4.9 | 3.6 | 0.5 | — | |
| Stock-based compensation | 0.6 | 0.3 | 0.5 | 0.5 | 0.4 | 0.5 | 1.4 | 1.3 | 0.9 | 1.5 | 2.3 | 3.4 | 4.5 | 3.2 | 7.5 | — |
USD millions · SEC XBRL
Transcat, Inc. — questions
- What is Transcat, Inc.'s operating cash flow?
- $40.0M over the twelve months to 2026-06-30.
- How much does Transcat, Inc. spend on capital expenditure?
- $14.7M over the twelve months to 2026-06-30.
- What is Transcat, Inc.'s free cash flow?
- $25.4M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Transcat, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.